Category: Sleep Disorders

Sleep Disorders

Phase 3 Trials Show Weight Loss for Triple Agonist with OSA Potential

'We now have the clinical data package to support global submissions for retatrutide as a potential treatment for obesity, knee osteoarthritis pain, and obstructive sleep apnea.'

Sleep Disorders

Surprisingly, Snoring Vibrations May Themselves Fuel Sleep Apnea Progression

A study suggests snoring is not just a symptom of OSA but may actively contribute to the sleep disorder.

Sleep Disorders

The Push Precision OSA Care Needed

For years, individualized obstructive sleep apnea care has been more aspiration than routine practice. Pharmacologic therapies may help change that.

Breathing Disorders

Consumer Sleep Data Likely Houses Clues to Cases of Undiagnosed OSA

But translating hundreds of different sleep trackers into a common language is a challenge. A team has taken on the task, which could ultimately lead to device-agnostic screening for obstructive sleep apnea.

Insomnia

Drug Used Off-Label for Insomnia Improves Sleep But Impairs Next-Day Alertness in OSA Patients

Flinders University researchers have led a clinical trial examining how a commonly prescribed ‘sleeping pill’ affects sleep, breathing, and next‑day performance.

Hypersomnias

Eli Lilly Completes Acquisition of Centessa Pharmaceuticals to Advance Narcolepsy Treatments

Eli Lilly and Company has completed its acquisition of Centessa Pharmaceuticals, securing a portfolio of clinical-stage orexin receptor 2 agonists. This strategic move aims to accelerate the development of new treatments for narcolepsy and other sleep-wake disorders.

Movement Disorders

Resmed Acquires Noctrix Health to Enter Restless Legs Syndrome Market

The acquisition adds the FDA-cleared, non-pharmacologic Nidra TOMAC therapy to Resmed’s portfolio, expanding its reach into the treatment of restless legs syndrome.

Circadian Rhythm Disorders

Drug Shows Promise for Reducing Excessive Sleepiness in Early Morning Shift Workers

A new clinical trial from Mass General Brigham found that a drug approved for other indications helped early morning shift workers with shift work disorder stay more alert.

Parasomnias

Teen Scholar Recognized for Research on Sleep Paralysis in Adolescents

Yanchen Wang is named among 300 scholars in the Regeneron Science Talent Search 2026 for her project investigating the characteristics and risk factors of the parasomnia.